Ultramicrosize Griseofulvin Tablet
Product Images NDC 62135-494
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ultramicrosize Griseofulvin (NDC 62135-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ndc 62135-494-01ultramicrosizegriseofulvintablets, Usp125 mgrx Only100 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 02)
Ndc 62135-494-30ultramicrosizegriseofulvintablets, Usp125 mgrx Only30 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 03)
Ndc 62135-495-01ultramicrosizegriseofulvintablets, Usp250 mgrx Only100 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 04)
This is a description of a medication called Ultramicrosize Griseofulvi in tablet form. The medication is available by prescription only and comes in a package with the National Drug Code 62135-495-01. The manufacturer of the medication is Chartwell Rx. The other text in the document is not available or readable.*
Ndc 62135-495-30ultramicrosizegriseofulvintablets, Usp250 mgrx Only30 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.